| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 620 | $70 | $44.1K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 160 | $220 | $34.3K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 30 | $730 | $24.1K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 150 | $90 | $13.2K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $140 | $12.1K |
| J9030 | BCG live intravesical instillation, 1 mg | 3,150 | $1 | $6.3K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 610 | $10 | $5.5K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 50 | $80 | $4.4K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 80 | $50 | $3.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $100 | $3.6K |